400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2022-10-25
Recursion Pharmaceuticals Inc
临床阶段生物药物研发商
医药研发/制造
化学&生物药
Invus;
Invus;
Kinnevik;
Kinnevik;
Baillie Gifford;
Mubadala;
Laurion Capital Management;
Platinum Asset Management
2020-09-09
Recursion Pharmaceuticals Inc
临床阶段生物药物研发商
医药研发/制造
化学&生物药
Samsara BioCapital;
Samsara BioCapital;
Catalio Capital Management;
Catalio Capital Management;
DCVC Bio;
Lux Capital;
Leaps by Bayer;
Casdin Capital;
EPIC Ventures;
Laurion Capital Management;
Intermountain Ventures;
Obvious Ventures;
Advantage Capital;
Felicis Ventures;
Baillie Gifford;
Mubadala;
Two Sigma Ventures
2019-07-15
Recursion Pharmaceuticals Inc
临床阶段生物药物研发商
医药研发/制造
化学&生物药
Lux Capital;
Lux Capital;
AME Cloud Ventures;
AME Cloud Ventures;
EPIC Ventures;
Obvious Ventures;
CRV;
Data Collective VC;
The University of Texas System;
University of Minnesota;
Felicis Ventures;
Mubadala;
Scottish Mortgage Investment Trust;
Intermountain Healthcare Innovation Fund;
Menlo;
Two Sigma Ventures
2018-05-07
Recursion Pharmaceuticals Inc
临床阶段生物药物研发商
医药研发/制造
化学&生物药
2017-10-04
Recursion Pharmaceuticals Inc
临床阶段生物药物研发商
医药研发/制造
化学&生物药
Lux Capital;
Lux Capital;
EPIC Ventures;
EPIC Ventures;
Mubadala;
Obvious Ventures;
CRV;
Advantage Capital;
Data Collective VC;
Felicis Ventures;
Menlo;
Two Sigma Ventures
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10